AlphaYouMA
Insider selling
Matt Abernethy sold $363K of Neurocrine Biosciences Inc (NBIX) stock
Matt Abernethy, Chief Financial Officer of Neurocrine Biosciences Inc (NBIX), sold 2,311 shares of NBIX stock worth $363K, per an SEC Form 4 filed Sep 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 11, 2026, 4 days before it was made public.
NBIX has moved -8.9% since the trade date, from $156.22 to $142.25 (Sep 22, 2026 close).
- Traded
- Sep 11, 2026
- Disclosed
- Sep 15, 2026
- Filing delay
- 4 days
- Price since
- -8.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More NBIX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.